LIPOFABRIK: A ground-breaking biomolecular production platform for safer, more efficient and sustainable pest control and crop health management.

Projektinformationen

LIPOFABRIK

ID Finanzhilfevereinbarung: 808000

DOI

10.3030/808000

Projekt abgeschlossen

EK-Unterschriftsdatum 31 Januar 2018

Startdatum 1 Januar 2018

Enddatum 30 April 2018

Finanziert unter

• SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy

Gesamtkosten

€ 71 429,00

EU-Beitrag

€ 50 000,00

Koordiniert durch

LIPOFABRIK
France

Periodic Reporting for period 1 - LIPOFABRIK (LIPOFABRIK: A ground-breaking biomolecular production platform for safer, more efficient and sustainable pest control and crop health management.)

Berichtszeitraum: 2018-01-01 bis 2018-04-30

Zusammenfassung vom Kontext und den Gesamtzielen des Projekts

The demand for the replacement of synthetic chemicals, for pest control, by biological solutions, with low toxicity for the environment and for human health, has increased in the last decade. In this scenario, we propose the use of lipopeptides and metabolites expressed by certain Bacillus subtilis strains. The advantages that those molecules offer for plant protection are known, however, their use is limited due to the capability to obtain bulk amounts of them. Our company holds patents for around lipopeptides and Bacillus metabolites. We have developed several products which have applications in plant protection market as antifungal, biostimulant and inducer of resistance. Currently we have set-up a bioprocess from our pilot line to obtain 50 kg/year products, we aim to scale-up the production to 90 tonnes/year It will allow us to satisfy the market demand and to offer these products at a competitive price.

Arbeit, die ab Beginn des Projekts bis zum Ende des durch den Bericht erfassten Berichtszeitraums geleistet wurde, und die wichtigsten bis dahin erzielten Ergebnisse

We have assessed the technical and commercial potential of our business idea and come with a realistic plan. The description of the technical activities have allowed us to identify all the services that we need to outsource, and the equipment that we have to buy. It has given us the information to estimate the investment needed and to plan how to get the capital we have to commit through capital share and funds of our company activities. Through the same industrial process we will obtain differents products with different applications, biostimulant and biopesticide. They will be distributed in EU and America by big companies from the seed to large cereal crop markets in the next 5 years. We feel confident with our plan to succeed with this business idea and have concluded that our product has the potential to be developed with the contribution of an additional funding.

Fortschritte, die über den aktuellen Stand der Technik hinausgehen und voraussichtliche potenzielle Auswirkungen (einschließlich der bis dato erzielten sozioökonomischen Auswirkungen und weiter gefassten gesellschaftlichen Auswirkungen des Projekts)

Most of the agricultors in the world often depend on chemical based pesticides and fertilizers for bounty agricultural output. However, during recent years, there is a change in the attitude of people towards pesticides due to their toxicity and ecotoxicity. As a result of this, stringent laws and regulations have been imposed for the safe use of agrochemicals. Consequently, the agrochemical companies are diverted their attention on the development of new molecules of biological origen. In this context, lipopeptides and other Bacillus metabolites, with proven activity against plant pathogens, eco-friendly and safe for human health, have an evident potential impact to be used in the plant protection market.

Lipofabrik logo

Bacillus sp. strain used to produce lipopeptides

Pilot plant